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Abstract 
Background: The prognosis of cirrhotic patients admitted to the ICU is considered to be poor but has been mainly 
reported in liver ICU. We aimed to describe the prognosis of cirrhotic patients admitted to a general ICU, to assess the 
predictors of mortality in this population, and, finally, to identify a subgroup of patients in whom intensive care escala‑
tion might be discussed.
Results: We performed a retrospective monocentric study of all cirrhotic patients consecutively admitted between 
2002 and 2014 in a general ICU in a regional university hospital. Two hundred and eighteen cirrhotic patients were 
admitted to the ICU. The 28‑day and 6‑month mortality rates were 53 and 74 %, respectively. Among the 115 patients 
who were discharged from ICU, only eight patients underwent liver transplantation, whereas 48 had no clear con‑
traindication. Multivariable analyses on 28‑day mortality identified three independent variables, incorporated into a 
new three‑variable prognostic model as follows: SOFA ≥ 12 (OR 4.2 [2.2–8.0]; 2 points), INR ≥ 2.6 (OR 2.5 [1.3–4.8]; 1 
point), and renal replacement therapy (OR 2.3 [1.1–5.1]; 1 point). For a value of the score at 4 (16 % of patients), 28‑day 
and 3‑month mortality rates were 91 and 100 %, respectively. An external validation of the score among 149 critically 
ill cirrhotic patients showed a good accuracy for predicting in‑ICU mortality.
Conclusions: Mortality of cirrhotic patients admitted to a general ICU was comparable to that of other studies. A 
pragmatic score integrating the SOFA score, INR, and the need for extrarenal epuration was strongly associated with 
mortality. Among the 16 % of patients presenting with score 4 at ICU admission, 100 % died in the 3‑month follow‑up 
period. The prognostic evaluation on day 3 remains essential for the majority of patients. However, this score calcula‑
ble at ICU admission might identify patients in whom the benefit of intensive care escalation should be discussed, in 
particular when liver transplantation is contraindicated.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made.
Background
The recent developments in the global management of 
ICU patients and the improved understanding of cirrho-
sis physiopathology and complications probably account 
for the better short-term survival of cirrhotic patients 
reported in the latest studies [1]. Nonetheless, the prog-
nosis of cirrhotic patients admitted to the intensive care 
unit (ICU) remains poor. Data from the literature of the 
last decade describe ICU mortality ranging from 36 to 
65 % [2–5] and in-hospital mortality varying from 44 to 
86 % [6–8], suggesting that despite the initial control of 
organ failures before release from ICU, 8–21 % of addi-
tional patients die in the short term.
 An early prognostic assessment is crucial for discrimi-
nating the good candidates for ICU from those for whom 
the situation is hopeless despite strong therapeutic inter-
ventions. In this perspective, it has been demonstrated 
that standard prognostic scores used by hepatologists, 
such as MELD or Child–Pugh, are insufficient because 
of focusing on the liver without considering other fail-
ures and the hepatic state. The ICU general scores, which 
reflect the state of the main living functions, are more 
relevant, particularly in the short term [2, 9–11].
Recently, the literature has underlined the relevance of 
a prognostic assessment deferred to day 3, which seems 
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more reliable than an assessment on admission [2, 5, 12]. 
However, the application of such deferred prognostic 
assessment that can only occur in ICU raises two practi-
cal issues: The first is the “permissive” access of cirrhotic 
patients in ICU and the second is the interruption of 
organ replacement therapy at day 3 when the situation is 
deemed hopeless.
The primary objective of our study was to describe the 
short-term and long-term outcome of cirrhotic patients 
admitted to a non-specialized general ICU. The second-
ary objectives were, first, to analyze the performance 
of prognostic markers to predict 28-day mortality and, 
second, to develop and evaluate a new prognostic score 
determined at ICU admission that may identify patients 
with an extremely poor prognosis in whom intensive care 




This is an observational, monocentric cohort study car-
ried out in the medical ICU of the Besancon University 
Hospital. All cirrhotic patients (cirrhosis either histologi-
cally proven or diagnosis made by hepatologists accord-
ing to clinical, biological, and ultrasonographic criteria) 
admitted to our medical ICU between 01.01.2002 and 
30.05.2014 were included. When a patient had been 
admitted to ICU more than once, only the first admission 
was analyzed.
Data collection
For each patient, 170 clinical and paraclinical variables 
were collected from their medical charts. These param-
eters were known at ICU admission (n = 110) and during 
ICU stay (n  =  60). Clinical data included socio-demo-
graphic characteristics, comorbidities, cause of admis-
sion, history of cirrhosis, baseline clinical conditions, and 
therapeutics during ICU stay. Biological data included 
34 biochemical and bacteriological variables, allowing 
the calculation of 7 prognostic scores at baseline and day 
3. The prognostic scores assessed were the Child–Pugh 
score, MELD score, D’Amico classification, IGS II score, 
APACHE II score, SOFA score, and CLIF-SOFA score 
calculated as global scores.
The main assessment criterion was 28-day mortal-
ity. The vital status was confirmed by the review of the 
computer-based medical record of the hospital which 
complies information from all units (Axigate database). 
When a patient released hospital alive, if no data were 
available after this release, the time was censored at the 
date of hospital release for statistical analyses.
Statistical analyses
Qualitative variables were expressed by the number and 
percentages and compared by Fisher’s exact tests. Quan-
titative variables were expressed by the median and inter-
quartile range (IQR) and compared with Wilcoxon’s rank 
test. Survival analyses used the Kaplan–Meier model 
and log-rank tests. Multivariable analyses of predictors 
of mortality used a logistic regression model for 28-day 
mortality. Variables included in the multivariable model 
were chosen according to univariate analyses, their rel-
evance according to the literature, and the likelihood of 
collinearity based upon clinical judgment. Indeed, we 
considered that general ICU scores, all evaluating the risk 
of mortality and being based upon the sequential assess-
ment of organ failures, would be collinear. Similarly, we 
considered that validated biological variables of liver fail-
ure (i.e., bilirubin, prothrombin rate, and international 
normalized ratio) would be collinear. A multiple logis-
tic regression model was used for the creation of a new 
prognostic score, based on 28-day mortality, and tak-
ing into account variables collected at the time of ICU 
admission. This score incorporated among the general 
ICU scores, the markers of liver failure, and the medical 
interventions, the one of each which had the best prog-
nostic performance. The local score was externally evalu-
ated in a cohort of 149 cirrhotic patients admitted to the 
ICU of the Rouen University Hospital. Statistical analyses 
were performed using SAS 9.3.
Results
Patient baseline characteristics
In the study period, 7427 admissions were recorded, 
including 258 (3.5  %) admissions for cirrhosis-related 
complications. Those 258 admissions corresponded to 
218 patients. The baseline characteristics of patients are 
described in Additional file  1: Table S1. Care and out-
come in ICU are described in Additional file 2: Table S2. 
Briefly, the median age was 59 [51–67], there were 165 
men (76  %), and alcoholism was the main cause of cir-
rhosis (85 %). On admission, the medians of the different 
prognostic scores were as follows: Child–Pugh = 11 [IQR 
9–12], MELD =  28 [18–40], SOFA =  12 [9–15], CLIF-
SOFA 14 [11–17], and IGS II = 59 [45–72]. The reasons 
for admission included: hemodynamic failure (53  %), 
coma (53  %), respiratory failure (36  %), renal failure 
(25 %), septic shock (17 %), and gastrointestinal bleeding 
(13 %). One hundred and four patients (48 %) had more 
than one reason for ICU admission. During ICU stay, 
190 patients needed mechanical ventilation (90  %). Of 
them, 173 (79 %) had been intubated at ICU admission. 
One hundred and eighty-seven patients (86  %) received 
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catecholamines and 112 (51  %) needed a renal replace-
ment therapy (22 of them (10 %) a MARS).
Outcome events
The median duration stay in ICU was 5 days [IQR 2–12]. 
The median duration of hospitalization was 13  days 
[4–36]. In-ICU, 28-day, 3-, 6-month, and 1-year mor-
tality rates were 47  % (103/218), 53  % (116/218), 66  % 
(139/210), 74  % (145/196), and 77  % (147/190), respec-
tively (Additional file  2: Table S2; Additional file  3: Fig. 
S1).
The outcome of the 115 ICU survivors is described in 
Additional file  4: Fig. S2. Forty-eight cirrhotic patients 
were apparently eligible for liver transplantation accord-
ing to our retrospective review. Conversely, 67 patients 
were not good candidates because of old age (n  =  19), 
alcohol dependence (n  =  34), possible advanced hepa-
tocellular carcinoma (n = 6), or extrahepatic malignancy 
(n  =  12). Finally, only eight (17  %) patients underwent 
liver transplantation after their ICU stay.
Univariate analysis according to the study period
Renal replacement therapy at ICU admission was per-
formed in 25 and 25  % of the patients before and after 
2010 (p = 1). Catecholamine use at ICU admission was 
given in 64 and 77 % of the patients before and after 2010, 
respectively (p = 0.04). Mechanical ventilation was pre-
sent in 62 and 76 % of the patients before and after 2010, 
respectively (p  =  0.03). Liver transplantation during or 
after ICU stay was performed in five patients in the first 
study period and in three patients in the second study 
period. The SOFA score at ICU admission was not sig-
nificantly different between these two periods (medians 
of 11 and 12, respectively, p = 0.25).
Univariate analysis of factors associated with 28‑day 
mortality
Results of univariate analysis of factors associated with 
28-day mortality are given in Table  1. Factors signifi-
cantly associated with 28-day mortality included low 
body temperature, low arterial pressure, admission for 
severe sepsis or septic shock, high INR, high plasma 
concentrations of creatinine, lactate, and bilirubin, low 
pH, PaO2/FiO2, platelet count, low albumin, low pro-
thrombin rate, the need of mechanical ventilation, renal 
replacement therapy, catecholamines, and high levels of 
all prognostic scores. The period of admission (before or 
after 2010) did not have significant impact on mortality 
(log rank p = 0.45).
Multivariable analysis of predictors of mortality
We aimed to build a multivariable model including 
the best general ICU score, the best biological variable 
of hepatic failure, and the most relevant therapy per-
formed at ICU admission. Among general ICU score 
(SOFA score, CLIF-SOFA, APACHE II), the SOFA score 
was the variable which was the most strongly associ-
ated with 28-day mortality. Among biological variables 
of liver failure, INR was the variable which was the most 
strongly associated with 28-day mortality. Among varia-
bles of treatment at the time of ICU admission (i.e., renal 
replacement therapy, catecholamine use, and mechanical 
ventilation), RRT was the variable which was the most 
strongly associated with 28-day mortality. According to 
these results, we built a multivariable model including the 
SOFA score, INR, and RRT. For the analysis, the SOFA 
score and INR were dichotomized at their median value 
in the cohort, respectively, 12 and 2.6. The results of mul-
tiple logistic regressions of variables relating to 28-day 
mortality are given in Table 2. These three variables were 
independently associated with 28-day mortality: baseline 
SOFA score ≥  12 (OR 4.2 [2.2–8.0]), INR ≥  2.6 at ICU 
admission (OR 2.5 [1.3–4.8]), and need for RRT at ICU 
admission (OR 2.3 [1.1–5.1]).
Creation of a local prognostic score at ICU admission 
and assessment of its performance
To give to the clinician a pragmatic, powerful, and easy-to-
use tool, we created a prognostic score at ICU admission, 
called “three-variable prognosis score” to predict 28-day 
mortality. This score incorporated the three independent 
mortality risk factors identified by multivariable analysis, 
each variable of the score being weighted by its odds ratio. 
Baseline SOFA score ≥  12 was associated with 2 points; 
INR ≥ 2.6 at ICU admission was associated with 1 point; 
and need for RRT at ICU admission was associated with 
1 point (Table  3). This score varied from 0 to 4 points 
and was significantly associated with mortality (log rank 
p  <  0.0001, Fig.  1). Log-rank test comparing each strata 
of the score with each other found that the survival prob-
ability for score =  3 and score =  4 was different of each 
other strata (Additional file 5: Table S3; Additional file 6: 
Fig. S3). AUC of the score for predicting 28-day mortality 
was 0.79 [0.73–0.84]. This score calculated at ICU admis-
sion was able to discriminate survivors and non-survivors 
at the times of ICU discharge, 28  days, 3, and 6  months 
(all p < 0.0001). Among patients presenting with score at 4 
(16 % of patients), 71 % (24/34) died in the first 3 days after 
ICU admission and 88 % (30/34) died in the first 10 days. 
For a value of the score at 4, the prediction of 28-day mor-
tality and 3-month mortality was excellent (positive pre-
dictive value of 91 and 100 %, respectively). 
External validation of the prognostic local score
The prognostic value of the local score was evaluated in 
a cohort of 149 critically ill cirrhotic patients admitted 
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Table 1 Predictive factors of 28-day mortality determined by univariate analysis in 218 cirrhotic patients admitted to the 
ICU
28‑day survivors (n = 102) 28‑day non‑survivors (n = 116) p
Variable
 Age 57 (50–66) 59 (51–68) 0.47
 Male sex 75 (74) 90 (78) 0.53
 Hepatology transfer 31 (30) 54 (47) 0.02
 Diabetes mellitus 36 (35) 24 (21) 0.02
 Smoker 88 (86) 89 (77) 0.08
 Chronic renal failure 9 (9) 10 (9) 1
 Cancer 15 (15) 15 (13) 0.84
Characteristics of cirrhosis
 Alcoholic cause 83 (81) 101 (88) 0.26
 Viral cause 14 (14) 18 (16) 0.70
 Esophageal varices 72 (71) 86 (75) 0.54
 Ascites 63 (62) 86 (74) 0.06
Diagnosis at ICU admission
 Hemodynamic failure 34 (34) 81 (70) <0.0001
 Gastrointestinal bleeding 13 (13) 15 (13) 1
 Respiratory failure 43 (42) 36 (31) 0.09
 Severe sepsis 18 (18) 42 (36) 0.002
 Septic shock 12 (12) 26 (22) 0.048
 Renal failure 20 (20) 34 (29) 0.12
 Neurological failure 60 (59) 56 (48) 0.14
 Cardiorespiratory arrest 2 (2) 16 (14) 0.002
Clinical parameters at ICU admission
 Temperature 37.0 (36.1–37.6) 36.0 (35.0–37.0) <0.0001
 Systolic arterial pressure 110 (100–126) 100 (90–112) <0.0001
 Mean arterial pressure 70 (65–80) 62 (55–68) <0.0001
Biological parameters at ICU admission
 International normalized ratio 2.1 (1.7–2.8) 3.6 (2.3–6.5) <0.0001
 Blood glucose (mmol/L) 7.4 (6.0–9.5) 6.0 (3.7–8.4) 0.0002
 Creatinine (µmol/L) 127 (78–210) 186 (118–293) 0.001
 pH 7.37 (7.29–7.44) 7.25 (7.09–7.39) <0.0001
 Lactate (mmol/L) 2.4 (1.7–3.6) 4.7 (2.5–11.3) <0.0001
 PaO2/FiO2 290 (190–400) 200 (118–348) 0.003
 White blood cells (×109/L) 10.5 (7.4–15.5) 12.5 (8.4–19.0) 0.03
 Hemoglobin (g/dL) 9.9 (8.8–11.4) 8.8 (7.4–11.0) 0.005
 Platelets (×109/L) 113 (79–172) 90 (62–141) 0.005
 Bilirubin (µmol/L) 37 (20–90) 112 (34–248) <0.0001
 Albumin (g/L) 26 (22–30) 22 (18–28) 0.002
 Prothrombin rate (%) 43 (33–54) 25 (16–39) <0.0001
Prognostic scores at ICU admission
 Child–Pugh 10 (8–12) 11 (10–13) <0.0001
 MELD 21 (15–29) 35 (25–45) <0.0001
 IGS II 49 (39–60) 68 (57–81) <0.0001
 APACHE II 23 (18–27) 28 (23–34) <0.0001
 SOFA 10 (7–12) 14 (11–17) <0.0001
 CLIF‑SOFA 13 (10–15) 16 (13–19) <0.0001
Prognostic score after ICU admission
 SOFA at day 3 8 (5–10) 16 (12–19) <0.0001
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to the ICU of the Rouen University Hospital (Table  4). 
These patients had a cirrhosis histologically proven or a 
diagnosis of cirrhosis made by hepatologists according 
to clinical, biological, and ultrasonographic criteria. The 
median age was 56  years (50–62), median INR was 2.2 
(1.6–3.0), median SOFA score at ICU admission was 11 
[7–14], renal replacement therapy was performed in 22 
patients (15 %), and in-ICU mortality was 38 %. In-ICU 
mortality was 11, 25, 62, 66, and 85  % among patients 
presenting with local score equal to 0, 1, 2, 3, and 4, 
respectively (Table 4). In-hospital mortality was 100 % for 
patients with score equal to 4 at ICU admission. Among 
the 13 patients classified score 4 (i.e., those having SOFA 
score ≥ 12 and INR ≥ 2.6 and need for RRT), RRT was 
indicated but not performed in seven patients despite a 
deep metabolic acidosis, because of lack of time, because 
of the death occurring in the first hours after admission, 
or because the clinician estimated that the patient was 
moribund and RRT was futile. These seven patients died 
within 24 h of ICU admission.
Discussion
This monocentric cohort study has evaluated the mor-
tality risk factors in 218 cirrhotic patients consecutively 
admitted to our general ICU and reports two main 
results: (1) the prognosis of cirrhotic patients admitted 
to non-specialized general ICU is comparable to that 
of other studies, but the long-term prognosis is poor in 
the absence of liver transplantation; (2) a new prognos-
tic score combining SOFA, INR, and the need for renal 
replacement therapy improves the prognostic assessment 
at baseline and could make usefulness the delayed assess-
ment at day 3 in 16 % of patients.
Our study had the merit to collect exhaustive informa-
tion in a non-selected population from a general ICU in 
a regional university hospital. Although the proportion 
of admission for complicated cirrhosis was low during 
the study period (3.5 %), we were able to report the long-
term outcome of almost 200 patients, making our cohort 
larger than others reported in the majority of published 
studies on the topic.
In our center, the overall mortality of patients admit-
ted between 2002 and 2014 in our ICU was around 30 %, 
comparable to that of the literature. In cirrhotic patients, 
in-ICU mortality was 47  % and was also comparable to 
that reported in the literature of the last decade, since 
it ranges from 36 to 65  % [2–5]. Regarding in-ICU and 
28-day mortality rates, our data were similar to the 41 % 
in-ICU and 54  % 28-day mortality rates reported by 
Das et al. [5], but higher to that reported by Flood et al. 
[13]. The discrepancies are probably the consequence of 
the severity of the patients at admission. Interestingly, 
our results were obtained in a population with a high 
Numbers are n (%), median [interquartile range], MARS molecular adsorbent recirculating system
Table 1 continued
28‑day survivors (n = 102) 28‑day non‑survivors (n = 116) p
Clinical feature during ICU stay
 Mechanical invasive ventilation 76 (75) 106 (91) 0.009
 Vasopressor therapy 78 (76) 109 (94) 0.0003
 Renal replacement therapy 28 (27) 84 (72) <0.0001
 MARS 8 (8) 14 (12) 0.37
Clinical course in ICU
 Documented infection 76 (75) 94 (81) 0.26
 Severe sepsis 56 (55) 88 (76) 0.002
 Septic shock 35 (34) 63 (54) 0.004
 Gastrointestinal bleeding 30 (29) 39 (34) 0.56
 Hepatic encephalopathy 64 (63) 57 (49) 0.06
Table 2 Logistic regression analyses of  factors associated 
with 28-day mortality
INR international normalized ratio, SOFA sequential organ failure assessment 
score
Variable Simple logistic regression 
model
Multiple logistic  
regression model
OR [CI 95 %] p OR [CI 95 %] p
SOFA score
 <12 1 <0.0001 1 <0.0001
 ≥12 5.6 [3.1–9.9] 4.2 [2.2–8.0]
INR
 <2.6 1 <0.0001 1 0.008
 ≥2.6 4.5 [2.5–8.2] 2.5 [1.3–4.8]
Renal replacement therapy
 No 1 0.0004 1 0.03
 Yes 3.4 [1.7–6.8] 2.3 [1.1–5.1]
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proportion of mechanical ventilation (90  %). Regarding 
long-term mortality, our results were close to the 38  % 
6-month survival given by Das [5] and the 31 % one-year 
survival given by Gildea [6].
The result of initial prognostic assessments was con-
sistent with the literature data. In particular, we found a 
good performance of organ dysfunction scores: A high 
SOFA score was particularly a good predictor of in-ICU 
Table 3 Prognostic score at ICU admission and its performance
INR international normalized ratio, SOFA sequential organ failure assessment score







Indication of renal replacement therapy
 No 0
 Yes 1
Total score (0–4 points)







0 point 14/60 (23) 22/56 (39) 26/47 (55)
1 point 16/33 (48) 19/30 (63) 20/30 (67)
2 points 15/36 (42) 21/35 (60) 21/33 (64)
3 points 31/40 (78) 32/40 (80) 32/37 (86)
4 points 31/34 (91) 34/34 (100) 34/34 (100)
Fig. 1 Survival according to our three‑variable prognostic score
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mortality as reported in the study by Levesque et al. [2]. 
However, we wanted to improve our initial prognostic 
assessment as much as possible, and this is why we cre-
ated a new composite score from this series. The statisti-
cal analyses allowed us to identify the best score of organ 
failures, the best marker of liver failure, and the most rel-
evant organ replacement therapy to predict in-ICU mor-
tality. Thus, the three following variables: SOFA  ≥  12, 
INR ≥ 2.6, and need for renal replacement therapy, were 
selected and incorporated in our new composite score. 
This score was efficient for the evaluation of short-term 
and long-term survival.
Recent literature has emphasized the value of a 
deferred assessment at day 3, justifying in practice a 
permissive attitude consisting of undertaking intensive 
support without restriction but with a re-evaluation 
by SOFA or modified SOFA score after 72  h [5, 11]. In 
that context, Ginès et al. [14] indicated that therapeutic 
limitation could be considered if more than 3 organ fail-
ures persist at day 3. Such assessment deferred at day 3 
is problematic in everyday practice, when considering the 
financial and human investment it represents, which may 
appear disproportionated given the suboptimal efficiency 
of life supports in these patients. In our center, the imple-
mentation of therapeutic limitations remains difficult 
and inconstant. This is why we wanted to optimize and 
maximize the predictive value of the initial evaluation to 
establish a thinner selection of cirrhotic candidates for 
admission in ICU. Our new prognostic score partially 
solved this issue. A score equal to 4 at ICU admission was 
associated with a predictive value of 100 % for 3-month 
mortality. Similarly, in-hospital mortality was 100  % 
among patients with score equal to 4 in the validation 
cohort of the Rouen University Hospital.
Further progress concerns the “hepatology” manage-
ment of these patients. Surprisingly, although priority 
is given in France to the sickest patients for organ allo-
cation, only 17  % of patients eligible for transplanta-
tion actually underwent liver transplantation after their 
ICU stay in our series. This paradox is not specific to 
our center and has been clearly highlighted by a meta-
analysis dedicated to the prognosis of more than 2600 
cirrhotic patients admitted to ICU and included in 13 
international studies: Only 3  % of those patients under-
went liver transplantation, whereas 55 % survived to ICU 
stay (Vincent Di Martino, personal communication). We 
think an ICU stay should be considered as a major event 
in the natural history of cirrhosis, able to indicate per se 
a liver transplantation, as well as other events such as a 
spontaneous bacterial peritonitis.
Our study acknowledges several limitations: (1) This 
was a retrospective, monocentric, and observational 
study. However, an external validation of our local score 
showed a good accuracy for predicting in-ICU mortality 
in 149 critically ill cirrhotic patients. In this cohort, there 
was only 9 % patient with a score equal to 4, suggesting 
that patients considered as moribund may not be system-
atically admitted to the ICU. (2) The population of cir-
rhotic patients who have not been admitted to ICU and 
the reasons why ICU admission did or not occur are not 
known. This selection of patients undoubtedly influenced 
our results in “real life.” However, this criticism applies to 
all of the series previously published, because the selec-
tion procedures regulating access to ICUs of cirrhotic 
patients were never described. (3) The inclusion period 
did not allow us to investigate the prognostic impact of 
new anti-HCV drugs. (4) As in other studies, our statis-
tical analyses and the determination of our prognostic 
score presupposed that each relevant variable was not 
linked to the others. However, it is clear that in those 
patients, organ failures are intricate and also correlated 
with the degree of liver failure, the reasons for admis-
sion, and the therapeutic interventions. In this context, 
it is probably unrealistic to argue for the identification 
of entirely “independent” variables. (5) The long-term 
analyses were conducted on the entire population, which 
probably overestimates the impact of initial assessments 
(especially prognostic scores) because the largest propor-
tion of deaths occurs in ICU. It would have been more 
appropriate to perform a specific analysis restricted to 
the 115 patients who survived their ICU stay. However, 
such analysis would probably have been hampered by a 
lack of power, making difficult the interpretation of nega-
tive results. (6) This study reported critically ill patients 
admitted to the ICU for medical reasons, and thus, perio-
perative surgical population was not present in this study. 
(7) Large prospective validation of this score is necessary 
before raising definitive conclusions, especially on the 
possibility to avoid an assessment on day 3 for the most 
seriously ill patients.
In conclusion, the mortality of cirrhotic patients admit-
ted to a general ICU was comparable to that of other 
studies. The long-term prognosis of critically ill cirrhotic 
Table 4 External validation of  the local score in  a cohort 
of 149 cirrhotic patients admitted to the ICU of the Rouen 
University Hospital
Numbers are n (%)
Local score In‑ICU mortality
(n = 149)
0 point 7/62 (11)
1 point 6/24 (25)
2 points 13/21 (62)
3 points 19/29 (66)
4 points 11/13 (85)
Page 8 of 8Piton et al. Ann. Intensive Care  (2016) 6:94 
patients remains poor in the absence of liver transplan-
tation. A pragmatic score calculable at ICU admission 
might identify patients in whom the benefit of intensive 
care escalation should be discussed, in particular when 
liver transplantation is contraindicated.
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